For reliable analysis and quantification of protein expression and Tissue Phenomics®, it needs tissues that have been collected under highly standardized conditions as studies from Indivumed have demonstrated. Therefore, Indivumed has established within the past 14 years a unique global clinical infrastructure with leading cancer clinics addressing these scientific challenges for preclinical research, clinical trials and subsequently patient care using precision medicine.
Not sure if you want to exhibit at or attend the Tissue Collection Standards Determine the Future of Precision Medicine? See the panels below to get the information you need to make an informed decision.
|Conference/Event Dates:||10/18/2016 - 10/18/2016|
|Primary Industry:||Clinical Pharmacology|
|Other Industries:||Clinical Pharmacology, Professional Healthcare|
|Audience:||This webinar will be ideal for Medical, Pharmaceutical, Biotech and Diagnostics executives, VPs and Directors of therapeutic areas, and Chief Scientific, Medical and Executive Officers.
It will also be informative for lab and study directors, and medical directors.
|Booth Size||Booth Cost||Available Amenities|
|Marketing Vehicles Allowed:||n/a|
|Other Booth Sizes Available: n/a|
How do I show up here?
Add a note here, it is only visible by you.